Published in Pediatr Nephrol on December 02, 2011
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. Kidney Int (2014) 3.40
A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy. J Am Soc Nephrol (2016) 1.50
Biopsy timing and Oxford classification variables in childhood/adolescent IgA nephropathy. Pediatr Nephrol (2014) 1.43
Reproducibility for pathological prognostic parameters of the Oxford classification of IgA nephropathy: a Japanese cohort study of the Ministry of Health, Labor and Welfare. Clin Exp Nephrol (2016) 1.11
New developments in the genetics, pathogenesis, and therapy of IgA nephropathy. Kidney Int (2015) 1.04
Serum levels of galactose-deficient immunoglobulin (Ig) A1 and related immune complex are associated with disease activity of IgA nephropathy. Clin Exp Nephrol (2014) 1.00
Validation of the Oxford classification of IgA nephropathy for pediatric patients from China. BMC Nephrol (2012) 0.97
Significance of immunohistochemical findings in Oxford classification of IgA nephropathy: The need for more validation studies. J Nephropathol (2013) 0.94
Treatment of IgA nephropathy and Henoch-Schönlein nephritis. Nat Rev Nephrol (2013) 0.90
The new histopathologic classification of ANCA-associated GN and its association with renal outcomes in childhood. Clin J Am Soc Nephrol (2014) 0.84
Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort. Pediatr Nephrol (2016) 0.81
Spontaneous remission in children with IgA nephropathy. Pediatr Nephrol (2012) 0.81
Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy. Pediatr Nephrol (2017) 0.78
Long-term morbidity of IgA nephropathy in children evaluated with newly proposed remission criteria in Japan. Clin Exp Nephrol (2015) 0.77
Studying cytokines of T helper cells in the kidney disease of IgA vasculitis (Henoch-Schönlein purpura). Pediatr Nephrol (2015) 0.77
The difficulty in considering modifiable pathology risk factors in children with IgA nephropathy: crescents and timing of renal biopsy. Pediatr Nephrol (2014) 0.77
Update on immunoglobulin a nephropathy. Part II: Clinical, diagnostic and therapeutical aspects. World J Nephrol (2016) 0.75
Clinical outcomes of IgA nephropathy patients with different proportions of crescents. Medicine (Baltimore) (2017) 0.75
Primary glomerulonephritis: A review of important recent discoveries. Kidney Res Clin Pract (2013) 0.75
The Japanese Histologic Classification and T-score in the Oxford Classification system could predict renal outcome in Japanese IgA nephropathy patients. Clin Exp Nephrol (2017) 0.75
Long-term outcome of childhood IgA nephropathy with minimal proteinuria. Pediatr Nephrol (2015) 0.75
Evaluation of crescent formation as a predictive marker in immunoglobulin A nephropathy: a systematic review and meta-analysis. Oncotarget (2017) 0.75
Redefining lupus nephritis: clinical implications of pathophysiologic subtypes. Nat Rev Nephrol (2017) 0.75
A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics (1976) 13.83
The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int (2009) 7.45
The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int (2009) 7.19
IgA nephropathy. N Engl J Med (2002) 5.85
National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics (2003) 3.10
The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. Kidney Int (2010) 2.14
Treatment of IgA nephropathy. Kidney Int (2006) 1.98
Pathophysiology and treatment of IgA nephropathy in children. Pediatr Nephrol (2001) 1.85
Improved renal survival in Japanese children with IgA nephropathy. Pediatr Nephrol (2008) 1.67
A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group. J Am Soc Nephrol (1999) 1.60
Validation of the Oxford classification of IgA nephropathy. Kidney Int (2011) 1.53
The IgA nephropathy treatment dilemma. Kidney Int (2006) 1.39
Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial. Clin J Am Soc Nephrol (2006) 1.24
Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification). Nephrol Dial Transplant (2011) 1.17
Prognostic indicators in childhood IgA nephropathy. Nephron (1992) 1.11
Combination therapy with mizoribine for severe childhood IgA nephropathy: a pilot study. Pediatr Nephrol (2008) 1.04
Long-term results of a randomized controlled trial in childhood IgA nephropathy. Clin J Am Soc Nephrol (2011) 0.89
Treatment of primary IgA nephropathy. Kidney Int (2004) 0.88
Efficacy and safety of lisinopril for mild childhood IgA nephropathy: a pilot study. Pediatr Nephrol (2008) 0.85
Combined therapy with prednisolone, azathioprine, heparin-warfarin, and dipyridamole for paediatric patients with severe IgA nephropathy--is it relevant for adult patients? Nephrol Dial Transplant (1999) 0.81
Visualization of ATP levels inside single living cells with fluorescence resonance energy transfer-based genetically encoded indicators. Proc Natl Acad Sci U S A (2009) 3.57
The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. Kidney Int (2010) 2.14
Acute renal failure due to obstructive uric acid stones associated with acute gastroenteritis. Pediatr Nephrol (2009) 2.09
Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome. Pediatr Nephrol (2005) 2.08
Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol (2012) 1.95
Genotype-phenotype correlations in alternating hemiplegia of childhood. Neurology (2014) 1.82
Improved renal survival in Japanese children with IgA nephropathy. Pediatr Nephrol (2008) 1.67
Maintenance therapy with mycophenolate mofetil after rituximab in pediatric patients with steroid-dependent nephrotic syndrome. Pediatr Nephrol (2011) 1.67
Prospective 5-year follow-up of cyclosporine treatment in children with steroid-resistant nephrosis. Pediatr Nephrol (2013) 1.60
A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet (2012) 1.58
A deep intronic mutation in the SLC12A3 gene leads to Gitelman syndrome. Pediatr Res (2009) 1.57
Identification of FOXP3-negative regulatory T-like (CD4(+)CD25(+)CD127(low)) cells in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Clin Immunol (2011) 1.57
Morbidity in children with frequently relapsing nephrosis: 10-year follow-up of a randomized controlled trial. Pediatr Nephrol (2014) 1.53
Rituximab in refractory nephrotic syndrome. Pediatr Nephrol (2009) 1.51
Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children. Pediatr Nephrol (2009) 1.49
Rituximab treatment combined with methylprednisolone pulse therapy and immunosuppressants for childhood steroid-resistant nephrotic syndrome. Pediatr Nephrol (2014) 1.46
Biopsy timing and Oxford classification variables in childhood/adolescent IgA nephropathy. Pediatr Nephrol (2014) 1.43
Treatment strategies for Henoch-Schönlein purpura nephritis by histological and clinical severity. Pediatr Nephrol (2011) 1.39
Renal biopsy criterion in children with asymptomatic constant isolated proteinuria. Nephrol Dial Transplant (2012) 1.38
Age, gender, and body length effects on reference serum creatinine levels determined by an enzymatic method in Japanese children: a multicenter study. Clin Exp Nephrol (2011) 1.31
Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial. Clin J Am Soc Nephrol (2006) 1.24
Japan Renal Biopsy Registry and Japan Kidney Disease Registry: Committee Report for 2009 and 2010. Clin Exp Nephrol (2013) 1.17
Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome. Kidney Int (2002) 1.10
Japan Renal Biopsy Registry: the first nationwide, web-based, and prospective registry system of renal biopsies in Japan. Clin Exp Nephrol (2011) 1.08
Analysis of NPHS1, NPHS2, ACTN4, and WT1 in Japanese patients with congenital nephrotic syndrome. Kidney Int (2005) 1.07
The pharmacological characteristics of molecular-based inherited salt-losing tubulopathies. J Clin Endocrinol Metab (2010) 1.07
Genetic disorders of human congenital anomalies of the kidney and urinary tract (CAKUT). Pediatr Int (2003) 1.05
Combination therapy with mizoribine for severe childhood IgA nephropathy: a pilot study. Pediatr Nephrol (2008) 1.04
HNF1B alterations associated with congenital anomalies of the kidney and urinary tract. Pediatr Nephrol (2010) 1.03
Mechanisms of development and progression of cyanotic nephropathy. Pediatr Nephrol (2006) 1.03
Two-year outcome of the ISKDC regimen and frequent-relapsing risk in children with idiopathic nephrotic syndrome. Clin J Am Soc Nephrol (2013) 1.02
Rituximab for refractory focal segmental glomerulosclerosis. Pediatr Nephrol (2007) 1.00
Cyclosporine and steroid therapy in children with steroid-resistant nephrotic syndrome. Pediatr Nephrol (2009) 1.00
Molecular analysis of patients with type III Bartter syndrome: picking up large heterozygous deletions with semiquantitative PCR. Pediatr Res (2007) 1.00
Epithelial-to-mesenchymal transition in cyst lining epithelial cells in an orthologous PCK rat model of autosomal-recessive polycystic kidney disease. Am J Physiol Renal Physiol (2010) 0.97
Acute encephalopathy and rhabdomyolysis following rotavirus gastroenteritis. J Paediatr Child Health (2007) 0.97
Recurrent deep intronic mutations in the SLC12A3 gene responsible for Gitelman's syndrome. Clin J Am Soc Nephrol (2010) 0.97
Natural history of genetically proven autosomal recessive Alport syndrome. Pediatr Nephrol (2014) 0.96
Reference ranges for serum cystatin C measurements in Japanese children by using 4 automated assays. Clin Exp Nephrol (2013) 0.96
Long-term follow-up of atypical membranoproliferative glomerulonephritis: are steroids indicated? Pediatr Nephrol (2005) 0.95
Membranous nephropathy associated with thyroid-peroxidase antigen. Pediatr Nephrol (2008) 0.94